{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T19:34:00Z","timestamp":1757619240321,"version":"3.44.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T00:00:00Z","timestamp":1753142400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T00:00:00Z","timestamp":1753142400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"DOI":"10.1186\/s12886-025-04251-0","type":"journal-article","created":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T07:49:57Z","timestamp":1753170597000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multicentric Castleman disease presenting with orbital involvement progressing to TAFRO syndrome: a case report"],"prefix":"10.1186","volume":"25","author":[{"given":"Yuanfeng","family":"Wei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiawei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangjian","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyue","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danning","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanru","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongping","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,22]]},"reference":[{"issue":"3","key":"4251_CR1","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1002\/hon.3075","volume":"41","author":"T Chen","year":"2023","unstructured":"Chen T, Feng C, Zhang X, Zhou J. TAFRO syndrome: A disease that known is half cured. Hematol Oncol. 2023;41(3):310\u201322.","journal-title":"Hematol Oncol"},{"issue":"1","key":"4251_CR2","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1186\/s12886-024-03775-1","volume":"24","author":"L Xu","year":"2024","unstructured":"Xu L, Li J, Xu X, Ren T, Ma J. Plasma cell type castleman\u2019s disease of lacrimal gland: a case report and literature review. BMC Ophthalmol. 2024;24(1):508.","journal-title":"BMC Ophthalmol"},{"issue":"4","key":"4251_CR3","doi-asserted-by":"publisher","first-page":"314","DOI":"10.3109\/01676830.2014.904381","volume":"33","author":"B Mukherjee","year":"2014","unstructured":"Mukherjee B, Alam MS, Krishnakumar S. A rare case of bilateral orbital Castleman disease. Orbit. 2014;33(4):314\u20137.","journal-title":"Orbit"},{"issue":"1","key":"4251_CR4","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/S0002-9394(99)00027-6","volume":"128","author":"T Kurokawa","year":"1999","unstructured":"Kurokawa T, Suzuki S, Kawaguchi K, Fujisawa N, Yoshimura N. Castleman disease presenting with ophthalmic signs and symptoms. Am J Ophthalmol. 1999;128(1):114\u20136.","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"4251_CR5","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.survophthal.2009.09.003","volume":"55","author":"I Venizelos","year":"2010","unstructured":"Venizelos I, Papathomas TG, Papathanasiou M, Cheva A, Garypidou V, Coupland S. Orbital involvement in Castleman disease. Surv Ophthalmol. 2010;55(3):247\u201355.","journal-title":"Surv Ophthalmol"},{"issue":"8","key":"4251_CR6","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.3390\/medicina59081381","volume":"59","author":"L-C Liu","year":"2023","unstructured":"Liu L-C, Chen Y-G, Liu N-T, Chen Y-H, Chien K-H. A rare case of orbital Castleman disease with overlapping IgG4-Related disease. Medicina. 2023;59(8):1381.","journal-title":"Medicina"},{"issue":"5","key":"4251_CR7","first-page":"320","volume":"51","author":"K Takai","year":"2010","unstructured":"Takai K, Nikkuni K, Shibuya H, Hashidate H. Thrombocytopenia with mild bone marrow fibrosis accompanied by fever, pleural effusion, Ascites and hepatosplenomegaly. [Rinsho Ketsueki] Japanese J Clin Hematol. 2010;51(5):320\u20135.","journal-title":"[Rinsho Ketsueki] Japanese J Clin Hematol"},{"issue":"3","key":"4251_CR8","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3960\/jslrt.24026","volume":"64","author":"T Uchiyama","year":"2024","unstructured":"Uchiyama T, Yokoyama A, Kuroda Y, Aoki S. Comparison of pathophysiological differences in TAFRO syndrome with or without lymphadenopathy. J Clin Experimental Hematopathology. 2024;64(3):208\u201315.","journal-title":"J Clin Experimental Hematopathology"},{"key":"4251_CR9","doi-asserted-by":"publisher","first-page":"6298","DOI":"10.1182\/blood-2024-204501","volume":"144","author":"S Li","year":"2024","unstructured":"Li S, Gao Y, Dang Y, Zhang L, Li J. Tafro syndrome without pathological evidence consistent with Castleman disease: A subtype of Tafro or a distinct disease. Entity? Blood. 2024;144:6298.","journal-title":"Entity? Blood"},{"key":"4251_CR10","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s00432-019-03120-w","volume":"146","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Suo S-S, Yang H-J, Zhou X-P, You L-S, Yu W-J, et al. Clinical features and treatment of 7 Chinese TAFRO syndromes from 96 de Novo Castleman diseases: a 10-year retrospective study. J Cancer Res Clin Oncol. 2020;146:357\u201365.","journal-title":"J Cancer Res Clin Oncol"},{"key":"4251_CR11","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3389\/fmed.2017.00149","volume":"4","author":"C Louis","year":"2017","unstructured":"Louis C, Vijgen S, Samii K, Chalandon Y, Terriou L, Launay D, et al. TAFRO syndrome in caucasians: a case report and review of the literature. Front Med. 2017;4:149.","journal-title":"Front Med"},{"issue":"4","key":"4251_CR12","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3960\/jslrt.19021","volume":"59","author":"Y Masaki","year":"2019","unstructured":"Masaki Y, Kawabata H, Fujimoto S, Kawano M, Iwaki N, Kotani T, et al. Epidemiological analysis of multicentric and unicentric Castleman disease and TAFRO syndrome in Japan. J Clin Experimental Hematopathology. 2019;59(4):175\u20138.","journal-title":"J Clin Experimental Hematopathology"},{"issue":"16","key":"4251_CR13","first-page":"1353","volume":"135","author":"A Dispenzieri","year":"2020","unstructured":"Dispenzieri A, Fajgenbaum DC. Overview of Castleman disease. Blood. J Am Soc Hematol. 2020;135(16):1353\u201364.","journal-title":"J Am Soc Hematol"},{"issue":"11","key":"4251_CR14","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1016\/S0161-6420(89)32674-1","volume":"96","author":"JW Gittinger Jr","year":"1989","unstructured":"Gittinger JW Jr. Ocular involvement in castleman\u2019s disease: response to radiotherapy. Ophthalmology. 1989;96(11):1646\u20139.","journal-title":"Ophthalmology"},{"issue":"1","key":"4251_CR15","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1136\/annrheumdis-2019-216561","volume":"79","author":"ZS Wallace","year":"2020","unstructured":"Wallace ZS, Naden RP, Chari S, Choi HK, Della-Torre E, Dicaire J-F, et al. The 2019 American college of rheumatology\/european league against rheumatism classification criteria for IgG4-related disease. Ann Rheum Dis. 2020;79(1):77\u201387.","journal-title":"Ann Rheum Dis"},{"issue":"19","key":"4251_CR16","first-page":"2924","volume":"123","author":"DC Fajgenbaum","year":"2014","unstructured":"Fajgenbaum DC, van Rhee F, Nabel CS. HHV-8-negative, idiopathic multicentric Castleman disease: novel insights into biology, pathogenesis, and therapy. Blood J Am Soc Hematol. 2014;123(19):2924\u201333.","journal-title":"Blood J Am Soc Hematol"},{"issue":"1","key":"4251_CR17","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1182\/bloodadvances.2020003607","volume":"5","author":"M-y Zhang","year":"2021","unstructured":"Zhang M-y, Jia M-n, Chen J, Feng J, Cao X-x, Zhou D-b, et al. UCD with MCD-like inflammatory state: surgical excision is highly effective. Blood Adv. 2021;5(1):122\u20138.","journal-title":"Blood Adv"},{"issue":"9","key":"4251_CR18","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1002\/ajh.25554","volume":"94","author":"S Fujimoto","year":"2019","unstructured":"Fujimoto S, Sakai T, Kawabata H, Kurose N, Yamada S, Takai K, et al. Is TAFRO syndrome a subtype of idiopathic multicentric Castleman disease? Am J Hematol. 2019;94(9):975\u201383.","journal-title":"Am J Hematol"},{"issue":"2","key":"4251_CR19","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1002\/ajh.24242","volume":"91","author":"N Iwaki","year":"2016","unstructured":"Iwaki N, Fajgenbaum DC, Nabel CS, Gion Y, Kondo E, Kawano M, et al. Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV-8\u2010negative multicentric Castleman disease. Am J Hematol. 2016;91(2):220\u20136.","journal-title":"Am J Hematol"},{"key":"4251_CR20","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s12185-020-03008-3","volume":"113","author":"S Fujimoto","year":"2021","unstructured":"Fujimoto S, Kawabata H, Sakai T, Yanagisawa H, Nishikori M, Nara K, et al. Optimal treatments for TAFRO syndrome: a retrospective surveillance study in Japan. Int J Hematol. 2021;113:73\u201380.","journal-title":"Int J Hematol"},{"issue":"9","key":"4251_CR21","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/S1470-2045(14)70319-5","volume":"15","author":"F Van Rhee","year":"2014","unstructured":"Van Rhee F, Wong RS, Munshi N, Rossi J-F, Ke X-Y, Foss\u00e5 A, et al. Siltuximab for multicentric castleman\u2019s disease: a randomised, double-blind, placebo-controlled trial. Lancet Oncol. 2014;15(9):966\u201374.","journal-title":"Lancet Oncol"},{"issue":"3","key":"4251_CR22","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/bjh.17868","volume":"196","author":"L Maisonobe","year":"2022","unstructured":"Maisonobe L, Bertinchamp R, Damian L, G\u00e9rard L, Berisha M, Guillet S, et al. Characteristics of thrombocytopenia, anasarca, fever, reticulin fibrosis and organomegaly syndrome: a retrospective study from a large Western cohort. Br J Haematol. 2022;196(3):599\u2013605.","journal-title":"Br J Haematol"},{"key":"4251_CR23","doi-asserted-by":"crossref","unstructured":"Palmeri S, Ferro J, Natoli V, Matucci-Cerinic C, Papa R, Rosina S, et al. Efficacy of High\u2010Dose intravenous Anakinra in pediatric TAFRO syndrome: report of two cases and literature review. Pediatr Blood Cancer. 2025;72(8):e31759.","DOI":"10.1002\/pbc.31759"},{"issue":"4","key":"4251_CR24","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1159\/000505458","volume":"45","author":"P Xia","year":"2020","unstructured":"Xia P, Zhang L, Zou M, Zhang T, Li R, Shi X, et al. Acute kidney injury caused by TAFRO syndrome in a Chinese patient: efficacy of long-term corticosteroids combined with bortezomib and cyclophosphamide. Kidney Blood Press Res. 2020;45(4):623\u201330.","journal-title":"Kidney Blood Press Res"},{"issue":"5","key":"4251_CR25","doi-asserted-by":"publisher","first-page":"719","DOI":"10.7326\/L20-1051","volume":"174","author":"M Killian","year":"2021","unstructured":"Killian M, Viel S, Chalayer E, Forest F, Grange S, Bonnefoy P-B, et al. JAK1\/2 Inhibition in severe TAFRO syndrome: a case report. Ann Intern Med. 2021;174(5):719\u201321.","journal-title":"Ann Intern Med"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-025-04251-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-025-04251-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-025-04251-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T17:24:24Z","timestamp":1757265864000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-025-04251-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,22]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4251"],"URL":"https:\/\/doi.org\/10.1186\/s12886-025-04251-0","relation":{},"ISSN":["1471-2415"],"issn-type":[{"type":"electronic","value":"1471-2415"}],"subject":[],"published":{"date-parts":[[2025,7,22]]},"assertion":[{"value":"31 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"421"}}